Login/Register
  • 中文
  • English

News

ORIENT PHARMA's Listing on the Emerging Stock Market Approved, Poised for Q3 Debut

On the 9th, the Taipei Exchange reviewed and approved ORIENT PHARMA’s application to be listed on the emerging stock market. If all proceeds smoothly, the company is expected to go public in the third quarter.

Read more
Jun 10, 2025
AmCad BioMed’s Real-Time AI-Enabled Handheld Ultrasound System Secures Order from Jordan, to Be Introduced into Royal Healthcare System
Jun 10, 2025
BRIGHTEN OPTIX Subsidiary in Mainland China Secures First Locally Manufactured Ortho-K Lens Registration Certificate
Jun 09, 2025
Taiwan Bio Therapeutics’ New Knee Osteoarthritis Drug Approved by TFDA for Phase III Clinical Trial
Jun 09, 2025
TWi Biotechnology Merges with DuKang Pharmaceuticals; Chairperson Wu Yi-Jun: Merger to Strengthen R&D Pipeline
Jun 09, 2025
OBI Pharma Announces First ADC Platform Technology Collaboration with TegMine for New Drug Development
Jun 09, 2025
CHLITINA Holding Reports Four Consecutive Months of Revenue Growth in May; Ex-Dividend Date Set for July 3
Jun 06, 2025
Alar’s ALA-1000 Aims to Enter Phase III Next Year; Licensing Partner Expected to Refocus
Jun 06, 2025
UNICOCELL BIOMED Advances Dual-Indication Allogeneic Cell Therapy, Progresses Toward Main Board Listing
Jun 06, 2025
VIZIONFOCUS Sees Strong 618 Sales for Daily Cosmetic Contact Lenses; Q2 Revenue Aiming for 10% Growth, Further Rise Expected in Q3

Most Watched

Recommended

DOHO Healing Programs (Detox, Facial, Aroma, Physical)
National Institute for Korean Medicine Development
LuminX Tracking Kit
LuminX Biotech Co., Ltd.
GI Hemo-stop powder and Its delivery device system
National Cheng Kung University Hospital

Industry Watch

Read more